The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension

Authors

  • Anggoro Budi Hartopo Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada – Sardjito Hospital, Yogyakarta, Indonesia http://orcid.org/0000-0002-6373-1033
  • Lucida Kris Dinarti Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada – Sardjito Hospital, Yogyakarta, Indonesia
  • Abdul S Wahab Department of Child Health, Faculty of Medicine Universitas Gadjah Mada – Sardjito Hospital, Yogyakarta, Indonesia

Keywords:

chronic thromboembolic pulmonary hypertension, diagnosis, pulmonary hypertension

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is currently underdiagnosis and consequently undertreatment in the clinical practice. A deficient in diagnostic modality and treatment availability especially in developing countries makes the CTEPH diagnosis unlikely to confirm. However, high index of clinical suspicion of CTEPH will lead to proper diagnosis and correct treatment  with significant reduction in morbidity and mortality. Left untreated, the mean survival time is 6.8 years and the three year mortality rate may be as high as 90 %. The pathophysiology, diagnosis and treatment of CTEPH are necessary to be shared among internists and primary care physicians, in order to improve the overall outcome of the patients.

Downloads

Published

2017-08-08

How to Cite

Hartopo, A. B., Dinarti, L. K., & Wahab, A. S. (2017). The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension. Acta Medica Indonesiana, 49(2), 183. Retrieved from https://www.actamedindones.org/index.php/ijim/article/view/235

Issue

Vol. 49 No. 2 (2017): Acta Medica Indonesiana

Section

CLINICAL PRACTICE

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.